1. Pharmaceuticals and Drug Development

FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia

Written by Posted on Less than 0 min read

NEW HAVEN, Conn., May 14, 2025 /PRNewswire/ — Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), today announced that the Division of Neurology 1 within FDA’s Office of Neuroscience informed the Company that they are extending the PDUFA date for…

Member since

More from Admin

Cluck once, and the river shakes: Inside the Amazon’s giant snake saga
  1. Life Sciences

Cluck once, and the river shakes: Inside the Amazon’s giant snake saga

As a child, I was fascinated by reports and documentaries about field research and often wondered what it took to be there and what kind of knowledge was being produced. Later, as an ecologist, I felt the need for approaches that better connected scientific research with real-world contexts. I became especially interested in perspectives that […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Number of fish species at risk of extinction fivefold higher than previous estimates, according to a new prediction

Researchers predict that 12.7% of marine teleost fish species are at risk of extinction, up fivefold from the International Union for Conservation of Nature’s prior estimate of 2.5%. Nicolas Loiseau and Nicolas Mouquet from the MARBEC Unit (the Marine Biodiversity, Exploitation and Conservation Unit) in Montpellier, France, and colleagues report these findings in a study […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Plant-derived secondary organic aerosols can act as mediators of plant-plant interactions

A new study published in Science reveals that plant-derived secondary organic aerosols (SOAs) can act as mediators of plant-plant interactions. This research was conducted through the cooperation of chemical ecologists, plant ecophysiologists and atmospheric physicists at the University of Eastern Finland. It is well known that plants release volatile organic compounds (VOCs) into the atmosphere […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Canada lynx historic vary in US seemingly wider than beforehand thought

A broader previous may imply a brighter future for Canada lynx within the U.S., in response to current analysis. The examine, printed within the journal Organic Conservation, signifies that lynx may do nicely sooner or later in elements of Utah, central Idaho and the Yellowstone Nationwide Park area, even contemplating local weather change and the […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

New plant leaf aging factor found

Osaka Metropolitan University. “New plant leaf aging factor found.” ScienceDaily. ScienceDaily, 30 May 2025. /releases/2025/05/250530124254.htm>. Osaka Metropolitan University. (2025, May 30). New plant leaf aging factor found. ScienceDaily. Retrieved May 30, 2025 from www.sciencedaily.com/releases/2025/05/250530124254.htm Osaka Metropolitan University. “New plant leaf aging factor found.” ScienceDaily. www.sciencedaily.com/releases/2025/05/250530124254.htm (accessed May 30, 2025). Endangered Plants; Agriculture and Food; Botany; […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

AI-designed DNA controls genes in healthy mammalian cells for first time

A study published today in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that can successfully control gene expression in healthy mammalian cells. Researchers at the Centre for Genomic Regulation (CRG) created an AI tool which dreams up DNA regulatory sequences not seen before in nature. The model can […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

A fossil first: Scientists find 1.5-million-year-old footprints of two different species of human ancestors at same spot

More than a million years ago, on a hot savannah teeming with wildlife near the shore of what would someday become Lake Turkana in Kenya, two completely different species of hominins may have passed each other as they scavenged for food. Scientists know this because they have examined 1.5-million-year-old fossils they unearthed and have concluded […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Largest protein yet discovered builds algal toxins

While seeking to unravel how marine algae create their chemically complex toxins, scientists at UC San Diego’s Scripps Institution of Oceanography have discovered the largest protein yet identified in biology. Uncovering the biological machinery the algae evolved to make its intricate toxin also revealed previously unknown strategies for assembling chemicals, which could unlock the development […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Large herbivores such as elephants, bison and moose contribute to tree diversity

Using global satellite data, a research team has mapped the tree cover of the world’s protected areas. The study shows that regions with abundant large herbivores in many settings have a more variable tree cover, which is expected to benefit biodiversity overall. Maintaining species-rich and resilient ecosystems is key to preserving biodiversity and mitigating climate […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)

Treatment for: Low-Grade Glioma Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG) BRISBANE, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease

Treatment for: EBV-Positive Post-Transplant Lymphoproliferative Disease Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease THOUSAND OAKS, Calif.–(BUSINESS WIRE) July 17, 2024 — Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic […]
Written by
  1. Biology

Securin regulates the spatiotemporal dynamics of separase

Separase regulates multiple aspects of the metaphase-to-anaphase transition. Separase cleaves cohesin to allow chromosome segregation and localizes to vesicles to promote exocytosis. The anaphase-promoting complex/cyclosome (APC/C) activates separase by ubiquitinating its inhibitory chaperone, securin, triggering its degradation. How this pathway controls the exocytic function of separase is unknown. During meiosis I, securin is degraded over […]
Written by
  1. Biology

The primary cilium as a gatekeeper of FGFR2 function

In this issue, Nita et al. (https://doi.org/10.1083/jcb.202311030) show that the primary cilium regulates FGFR2 signalling through spatial compartmentalization, enabling selective downstream activation. Disruption of ciliary localization in disease-linked FGFR2 variants highlights the role of the cilium as a signalling gatekeeper in development and disease. Admin Member since October 11, 2023 Loading + Follow Following
Written by
  1. Biology

Preserve or destroy: Orphan protein proteostasis and the heat shock response

Most eukaryotic genes encode polypeptides that are either obligate members of hetero-stoichiometric complexes or clients of organelle-targeting pathways. Proteins in these classes can be released from the ribosome as “orphans”—newly synthesized proteins not associated with their stoichiometric binding partner(s) and/or not targeted to their destination organelle. Here we integrate recent findings suggesting that although cells […]
Written by
  1. Biology

A function of TPL/TBL1-type corepressors is to nucleate the assembly of the preinitiation complex

The plant corepressor TPL is recruited to diverse chromatin contexts, yet its mechanism of repression remains unclear. Previously, we leveraged the fact that TPL retains its function in a synthetic transcriptional circuit in the yeast model Saccharomyces cerevisiae to localize repressive function to two distinct domains. Here, we employed two unbiased whole-genome approaches to map […]
Written by
  1. Clinical

Sirnaomics Announces Completion of STP707 Phase I Clinical Study with Strong Safety Profile and Disease Activity for the Treatment of Pancreatic Cancer Patients

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 28, 2024 Sirnaomics Ltd. (the “Company”, together with its subsidiaries, the “Group” or “Sirnaomics”; stock code: 2257), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the Group has completed STP707 Phase I clinical study with strong safety profile and […]
Written by
  1. Clinical

Invoice & Melinda Gates Medical Analysis Institute Initiates Part 3 Scientific Trial of Tuberculosis Vaccine Candidate

CAMBRIDGE, Mass., March 19, 2024. The Invoice & Melinda Gates Medical Analysis Institute (Gates MRI) right now introduced {that a} Part 3 scientific trial to evaluate the efficacy of the M72/AS01E tuberculosis (TB) vaccine candidate is now underway, with first doses given in South Africa, the place TB takes a heavy toll. If proven to […]
Written by
  1. Nonclinical

The Changing Landscape: Nonclinical Opportunities in a Shifting Healthcare Industry

Title: The Changing Landscape: Nonclinical Opportunities in a Shifting Healthcare Industry Introduction In recent years, the healthcare industry has been undergoing significant transformation, driven by various factors such as advances in technology, evolving patient needs, and changing regulations. This shifting landscape has given rise to a range of nonclinical job opportunities where skilled professionals can […]
Written by
Next
No Comments
Leave a comment Cancel
Comments to: FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.